Advanced search
Publication Cover
Acta Oncologica Volume 55, 2016 - Issue 3
Journal homepage
1,097
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: Urologic cancer

A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2

Anne V. SoerensenDepartment of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark, Correspondence[email protected]
,
Poul F. GeertsenDepartment of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark,
,
Ib J. ChristensenThe Finsen Laboratory, Rigshospitalet and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark,
,
Gregers G. HermannDepartment of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
,
Niels V. JensenDepartment of Oncology, Odense University Hospital, Odense, Denmark,
,
Kirsten FodeDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark,
,
Astrid PetersenDepartment of Pathology, Aalborg University Hospital, Aalborg, Denmark, and
,
Rickard SandinPfizer Oncology, Sollentuna, Sweden
&
Frede DonskovDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark,
show all
Pages 341-348 | Received 19 May 2015, Accepted 02 Sep 2015, Published online: 08 Oct 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Maria Møller Pedersen, Frede Donskov, Lars Pedersen, Zuo-Feng Zhang & Mette Nørgaard. (2020) Elevated neutrophil-lymphocyte ratio combined with hyponatremia indicate poor prognosis in renal cell carcinoma. Acta Oncologica 59:1, pages 13-19.
Read now
Michael I. Koukourakis & Alexandra Giatromanolaki. (2019) Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy. International Journal of Radiation Biology 95:4, pages 408-426.
Read now
P. Penttilä, P. Bono, K. Peltola & F. Donskov. (2018) Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact. Acta Oncologica 57:11, pages 1580-1585.
Read now
Hana Študentová, Denisa Vitásková & Bohuslav Melichar. (2018) Lenvatinib for the treatment of kidney cancer. Expert Review of Anticancer Therapy 18:6, pages 511-518.
Read now
Frede Donskov, Daniel Y C Heng & Brian I Rini. (2017) On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?. Expert Review of Anticancer Therapy 17:2, pages 97-99.
Read now
Carol Mansfield, Sandy Srinivas, Connie Chen, A. Brett Hauber, Subramanian Hariharan, Ewa Matczak & Rickard Sandin. (2016) The effect of information on preferences for treatments of metastatic renal cell carcinoma. Current Medical Research and Opinion 32:11, pages 1827-1838.
Read now

Articles from other publishers (5)

Cecilie Budolfsen, Julie Faber, Daniela Grimm, Marcus Krüger, Johann Bauer, Markus Wehland, Manfred Infanger & Nils Erik Magnusson. (2019) Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment. Current Vascular Pharmacology 17:6, pages 618-634.
Crossref
Niels Fristrup & Frede Donskov. (2019) Folic Acid Reduces Mucositis in Metastatic Renal Cell Carcinoma Patients: A Retrospective Study. Clinical Genitourinary Cancer 17:4, pages 254-259.
Crossref
James A. Kuzman, David D. Stenehjem, Joseph Merriman, Archana M. Agarwal, Shiven B. Patel, Andrew W. Hahn, Anitha Alex, Dan Albertson, David M. Gill & Neeraj Agarwal. (2017) Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma. BMC Urology 17:1.
Crossref
Mathias Bendtsen, Daniela Grimm, Johann Bauer, Markus Wehland, Petra Wise, Nils Magnusson, Manfred Infanger & Marcus Krüger. (2017) Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences 18:8, pages 1736.
Crossref
P. Penttilä, F. Donskov, J. Rautiola, K. Peltola, M. Laukka & P. Bono. (2017) Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma. European Journal of Cancer 81, pages 9-16.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.